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Neurogenin Promotes Neurogenesis and Inhibits
Glial Differentiation by Independent Mechanisms
embryonic stages behave in a manner that mimics the
normal process of development (Burrows et al., 1997; Qian
et al., 2000). Progenitors from rat embryonic day 14 (E14)
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Greenberg, 1995). In E14 cultures, astrocytes are onlyHarvard Medical School
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Neuronal differentiation is promoted by both platelet-Summary
derived growth factor (PDGF) and by neurotrophin-3
(NT3). The cytokines leukemia inhibitory factor (LIF) andThe mechanisms by which neural stem cells give rise
ciliary neurotrophic factor (CNTF) are potent inducersto neurons, astrocytes, or oligodendrocytes are begin-
of astrocyte production, and thyroid hormone inducesning to be elucidated. However, it is not known how
oligodendrocyte differentiation (Greenberg, 1995; Johethe specification of one cell lineage results in the sup-
et al., 1996; Bonni et al., 1997; Ghosh and Williams etpression of alternative fates. We find that in addition to
al., 1997).inducing neurogenesis, the bHLH transcription factor
LIF and CNTF exert their effects primarily via the JaK/neurogenin (Ngn1) inhibits the differentiation of neural
STAT signaling pathway (Bonni et al., 1997; Rajan andstem cells into astrocytes. While Ngn1 promotes neu-
McKay, 1998). LIF and CNTF bind to related receptors,rogenesis by functioning as a transcriptional activator,
which activate a receptor-associated tyrosine kinase,Ngn1 inhibits astrocyte differentiation by sequestering
the Janus kinase (JaK1) (Stahl and Yancopoulos, 1994).the CBP-Smad1 transcription complex away from
Activated JaK1 phosphorylates two cytoplasmic pro-astrocyte differentiation genes, and by inhibiting the
teins, the signal transducers and activators of transcrip-activation of STAT transcription factors that are neces-
tion 1 and 3 (STAT1 and STAT3). This leads to STATsary for gliogenesis. Thus, two distinct mechanisms are
dimerization and translocation to the nucleus where theinvolved in the activation and suppression of gene ex-
STATs activate cell type and stimulus-specific programspression during cell-fate specification by neurogenin.
of gene expression (Bonni et al., 1993).
Other factors, such as bone morphogenetic proteinIntroduction
(BMP), can enhance both neuronal and astrocyte differen-
tiation, depending on the age of the stimulated cortical
The mammalian cerebral cortex originates from a single
progenitors (Gross et al., 1996; Li et al., 1998). BMP-
layer of proliferating neuroepithelial cells. These progen-
induced astrocyte differentiation appears to be medi-
itor cells line the ventricular cavities and sequentially ated by the downstream Smad signaling proteins (Na-
give rise to the three major cell types of the brain: neu- kashima et al., 1999; M. N. V. and M. E. G., unpublished
rons, astrocytes, and oligodendrocytes. Neurogenesis results). BMPs bind a multimeric receptor, which in turn
precedes gliogenesis throughout the nervous system results in the direct phosphorylation of Smad1 (Hood-
(Bayer and Altman, 1991), and retroviral labeling tech- less et al., 1996). This permits Smad1 to dimerize with
niques have further shown that a single progenitor can Smad4 and to translocate to the nucleus (Massague,
give rise to both neurons and astrocytes (Turner and 1998), where these factors cooperate with STATs to
Cepko, 1987; Luskin et al., 1988; Price and Thurlow, activate glial-specific programs of gene expression (Na-
1988). It thus appears that a common cortical progenitor kashima et al., 1999).
cell gives rise first to a variety of layer-specific neurons The cooperation between Smads and STATs on glial
and then switches to producing astrocytes, and ulti- promoters such as the glial fibrillary acidic protein
mately oligodendrocytes. The molecular mechanisms (GFAP) promoter appears to be facilitated by a family
that orchestrate these sequential events during devel- of coactivator proteins termed p300/CBP. CBP (CREB
opment are unclear. binding protein) and p300 are ubiquitously expressed
In culture, cortical progenitor cells isolated at different and are involved in the transcriptional coactivation of
many different transcription factors (Goodman and
Smolik, 2000). STATs and Smads bind to different do-§ To whom correspondence should be addressed (e-mail: greenberg@
a1.tch.harvard.edu). mains of CBP/p300 (Nakashima et al., 1999), and the
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Figure 1. Ngn1 Promotes Neurogenesis and Inhibits Astrocyte Differentiation in E14 Rat Cortical Progenitor Cells
Primary rat E14 cortical cultures were infected with Ngn1 or Ngn1(nm)/control (con) retroviruses. Four days after plating/infection, cells were
fixed and subjected to immunostaining for neuronal (TuJ1) and astrocytic (GFAP) differentiation markers. Infected cells were positive for GFP
(A and C). In (C), but not in (A), cells were treated with CNTF for four days to promote astrocyte differentiation. The quantitative analyses of
the experiments are presented in (B) and (D) (*; p , 0.001).
STAT/p300/Smad complex, acting at the STAT binding role for neurogenic bHLH proteins in the developing
CNS has been substantiated by several recent knockoutelement in the astrocyte-specific GFAP promoter, is par-
ticularly effective at inducing astrocyte differentiation in studies (Ben-Arie et al., 1997; Fode et al., 2000; Tomita
et al., 2000).neural stem cells (Nakashima et al., 1999).
The signaling mechanisms by which neuronal or oligo- Despite recent progress, there is much that is still not
known about how different cell fates are determined indendrocytic cell fates are specified are less well under-
stood. However, several basic helix-loop-helix (bHLH) the developing cortex. A critical issue is how alternative
cell fates are suppressed. Inducers of neuronal fate musttranscription factors have been implicated as mediators
of neuronal or oligodendrocyte differentiation in the de- somehow suppress glial differentiation, and likewise,
glial differentiation can only proceed if the neuronal fateveloping CNS. These bHLH factors include oligo1 and
oligo2 for oligodendrocyte specification (Lu et al., 2000; is blocked. In this report, we demonstrate that Ngn1 effec-
tively inhibits astrocyte differentiation. We have identifiedZhou et al., 2000), and neurogenin1 and 2 (Ngn1 and
Ngn2), Mash1, and Math1 for neuronal differentiation two mechanisms by which Ngn1 represses glial-specific
gene transcription, (1) by sequestering the CBP/p300/(Guillemot et al., 1993; Ma et al., 1996; Ben-Arie et al.,
1997; Fode et al., 1998). Smad1 complex away from glial promoters, and (2) by
suppressing the JaK/STAT signaling pathway. As neuro-In the developing mammalian cerebral cortex, two
closely related bHLH factors, Ngn1 and Ngn2, are ex- genin levels are high during cortical neurogenesis and
low during gliogenesis, neurogenin’s ability to suppresspressed exclusively in the cortical ventricular zone,
where neuroepithelial precursor cells reside, and only glial differentiation may explain why astrocytes fail to
develop during the period of neurogenesis even in theduring the limited period of time when neurogenesis is
taking place (Gradwohl et al., 1996; Sommer et al., 1996; presence of glial-inducing cues.
Ma et al., 1997). Both Ngn1 and Ngn2 dimerize with
ubiquitous bHLH proteins, such as E12 or E47. These Results
heterodimers then bind via their positively charged basic
domains to DNA sequences that contain the E box con- Ngn1 Not Only Promotes Neurogenesis but Also
Inhibits Astrocyte Differentiationsensus motif, CANNTG (Gradwohl et al., 1996). E box
binding has been found to be critical for bHLH proteins In the cerebral cortex, Ngn1 and Ngn2 mRNAs are de-
tected exclusively in the ventricular zone, where theto activate tissue-specific gene expression that pro-
motes neuronal differentiation (Cau et al., 1997). The precursor cells reside, and only during the period of
Mechanisms of Neuronal-Glial Fate Determination
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Figure 2. Ngn1 Inhibits Various Aspects of the Astrocytic Phenotype in CNS Stem Cells and Mature Astrocytes
CNS stem cells were infected with Ngn1 or Ngn1(nm)/control (con) adenovirus. GFP was used to mark infected cells. Two days after infection
and treatment with CNTF, cells were fixed or lysed for immunocytochemistry (A), Western (B), or Northern (C) analysis and the levels of cell
type–specific markers were determined. In astrocyte-enriched cultures, virally expressed Ngn1 significantly reduced the protein levels of one
of the astrocytic markers, GFAP (D). Sample loading was normalized by assaying the levels of tubulin expression (see Western blot, D). Mature
astrocyte cultures were infected with the GFP/Ngn1 adenoviruses, and Ngn1 expression dramatically altered the astrocytic morphology and
cell adhesion (E).
cortical neurogenesis (Gradwohl et al., 1996; Sommer ronal cell fate determination, as opposed to merely pro-
moting neuronal differentiation, implies that Ngn1 induceset al., 1996; Ma et al., 1997). To examine whether Ngn1
can influence cell fate commitment, a retroviral vector neurogenesis at the expense of gliogenesis. During corti-
cal development, neurogenesis precedes glial differenti-was generated to introduce exogenous Ngn1 into divid-
ing cortical precursor cells cultured from rat E14 corti- ation. One possibility is that glial-inducing cues are only
expressed after neuronal differentiation is complete. Al-ces. For this analysis, we also used a control virus that
expresses a mutant Ngn1 gene, Ngn1(nm), with two stop ternatively, Ngn1 might actively inhibit gliogenesis even
in the presence of glial-inducing cues, ensuring that thecodons inserted after the initiator methionine codon, so
that no Ngn1 protein is produced. When cortical precur- process of neurogenesis is completed before gliogen-
esis can begin.sor cells were infected with the Ngn1 or Ngn1(nm)/con-
trol viruses, we found that exogenous Ngn1 expression To explore whether Ngn1 can still induce neurogenesis
in the presence of glial-inducing factors, we examined theled to a significant increase in the number of precursors
that become neurons, as compared with the control. effect of Ngn1 on neuronal and glial differentiation in cells
treated with LIF/CNTF. Ectopically expressed Ngn1, butNeurons were identified by cell morphology, and by the
expression of neuronal-specific markers such as the not Ngn1(nm)/control, was able to inhibit cytokine-
induced astrocyte differentiation in both cortical precur-b-tubulin/TuJ1 antigen (Figures 1A and 1B) and the mi-
crotubule-associated protein MAP2 (data not shown). sor and neural stem cell cultures. Astrocytes were identi-
fied by their morphology and by the expression of GFAP.In addition, the expression of Ngn1 led to downregula-
tion of the expression of the neuroepithelial precursor In E14 cortical cultures treated for four days with CNTF,
neurogenin expression reduced the number of GFAP-marker Nestin. This finding suggests that ectopic Ngn1
effectively induces the process of neuronal differentia- expressing astrocytes by 80% (Figures 1C and 1D). In
addition, Ngn1-expressing cells display a neuronal-liketion, rather than simply inducing the expression of se-
lected neuronal-specific markers in progenitor cells. morphology (small round cell bodies with one or two
simple processes) that is quite distinct from the stellateThe induction of neurogenesis by Ngn1 could be due
to enhanced neuronal survival or increased proliferation of GFAP-positive astrocytes. This implies that Ngn1 is not
only regulating GFAP expression but may also affectcommitted neuroblasts rather than neuronal differentiation
per se. However, the exogenous Ngn1-expressing cells other aspects of astrocyte differentiation.
The change in morphology is also seen when Ngn1do not show increased cell survival or proliferation rates
as compared with nonexpressing cells, ruling out either is expressed in neural stem cells in the presence of
CNTF, which would normally cause the differentiationof these alternative explanations (data not shown).
The possibility that Ngn1 instructively promotes neu- of virtually all of the stem cells into astrocytes (Figure
Cell
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Figure 3. Two or More Non-E box Elements in the Promoter of a Glial-specific Gene Are Involved in the Transcriptional Repression of This
Gene by Ngn1
The 1.9 kb rat GFAP promoter-luciferase-reporter construct was transfected, together with Ngn1 or Ngn1(nm)/control cDNA, into 1-week-old
E18 cortical astrocyte-enriched cultures. Ngn1 effectively inhibits the GFAP promoter even when the cells were treated with CNTF or BMP
(A). Deletion and mutation analysis of the GFAP promoter indicates that two DNA fragments are required for Ngn1 to inhibit the promoter (B).
Both fragments were found to lack E box or E box-like sequences. One of the fragments, however, contains a STAT binding site. Mutation
of this site renders the GFAP promoter more resistant to the suppression by Ngn1 (B) (*; p , 0.05).
2A) (Johe et al., 1996). Some of the Ngn1-expressing suggesting that Ngn1 inhibits various aspects of the
glial differentiation program.cells express the neuronal markers TuJ1 (Figure 2A) and
MAP2 (data not shown). The remaining Ngn1-expressing To investigate whether neurogenin can affect astrocyte-
specific gene expression after astrocytes have alreadycells are TuJ1 negative, but nonetheless fail to display
astrocytic morphology or GFAP expression. These find- differentiated, we introduced Ngn1 into astrocyte-enriched
cultures. Ngn1 overexpression clearly downregulatesings suggest that the suppression of astrocyte differenti-
ation in neural stem cells takes place before the induc- GFAP protein levels (Figure 2D). In the case of mature
astrocyte cultures, neurogenin expression also caused ation of neuronal differentiation.
The neural stem cell cultures, because they are ho- striking change in cell morphology and cell adhesion (Fig-
ure 2E). Though Ngn1 expression interferes with themogenous and display high (.90%) infection efficiency
to adenoviruses, are amenable to studies of gene ex- astrocytic phenotype of mature astrocyte cultures, it is
not capable of inducing neuronal-specific gene expressionpression using Western (Figure 2B) and Northern (Figure
2C) blot analyses. We generated adenoviruses express- in this context. Therefore, inhibition of astrocyte differenti-
ation by Ngn1 is not the passive result of enhanced neuro-ing either the Myc-tagged wild-type neurogenin (Myc-
Ngn1) or the Myc-Ngn1(nm)/control, which expresses genesis. Ngn1 appears to have two distinct roles: promot-
ing neurogenesis and inhibiting glial differentiation.six repeats of the Myc tag but no Ngn1 protein. Western
analysis indicates that Ngn1 inhibits the expression of
a glial marker, GFAP, and induces the expression of Transcriptional Repression by Ngn1 Is Dependent
on Non-E Box Promoter Elementsneuronal-specific b-tubulin (TuJ1 antigen) (Figure 2B).
By Northern analysis, we found that in CNS stem cells, To understand the mechanism by which Ngn1 inhibits
glial differentiation, we first examined whether Ngn1 ex-Ngn1 inhibits the CNTF/LIF-induced upregulation of
GFAP and another astrocyte marker s100b (Figure 2C), pression leads to the downregulation of glial-specific
Mechanisms of Neuronal-Glial Fate Determination
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Figure 4. Ngn1 Inhibits Astrocyte Differentia-
tion Independent of Its DNA Binding Domain
To examine whether Ngn1 can inhibit
astrocyte differentiation without directly
binding to DNA, we made two DNA binding
mutants of Ngn1 (D-Ngn1 and AQ-Ngn1) (A).
Both mutants failed to bind to the E box ele-
ment (see arrow for shift) (B). While the
D-mutation altered the subcellular localiza-
tion of Ngn1, the AQ-mutation was expressed
predominantly in the nucleus, as seen with
wild-type Ngn1 (C). When these mutants were
transiently transfected into CNS stem cells,
AQ-Ngn1 inhibited astrocyte differentiation
(D). Ngn1, but not AQ-Ngn1, activates
both the full NeuroD promoter and the three
E box elements of the NeuroD promoter, but
not a promoter construct with all three E
boxes mutated (E) (*; p , 0.05).
genes at the transcriptional level. Coexpression of Ngn1 of these two regions contains E box-like sequences, so
we searched for other known DNA binding elements.significantly suppressed GFAP promoter activity, even
when the cells were stimulated with glial-inducing fac- Using Transcription Element Search Software, we identi-
fied a putative c-Ets1 site at 21685 bp, an AP1 site attors such as CNTF/LIF or BMP (Figure 3A). Ngn1 similarly
suppressed the GFAP promoter-luciferase reporter ac- 21525 bp, a STAT binding site at 21435 bp, as well as
cryptic myogenin binding sites. A more detailed muta-tivity in neural stem cell cultures (data not shown). These
data suggest that Ngn1, either directly or indirectly, re- tional analysis, involving deletions and substitutions of
single and multiple sites, was undertaken. The resultspresses the transcription of glial-specific genes.
Neurogenin might inhibit astrocyte gene expression obtained suggest that, although the myogenin sites are
not involved, a number of the other identified sites asin one of three ways. There might be E box sequences
in astrocyte-specific promoters, and neurogenin might well as several novel sites, are important for the repres-
sion of the GFAP promoter by Ngn1. Of these sites,act as or recruit a transcriptional repressor to these
sites. Alternatively, Ngn1 might function as a transcrip- mutation of the STAT binding element, previously known
to be important for LIF/CNTF- and BMP-induced expres-tional activator (as it has classically been described),
upregulating a glial repressor. Lastly, neurogenin might sion of this gene (Bonni et al., 1997; Nakashima et al.,
1999), was most effective in reversing Ngn1 repressioninhibit astrocyte differentiation independent of its ability
to bind to DNA, for example, via a protein–protein inter- of the GFAP promoter activity (Figure 3B).
Though it appears that the STAT binding site is re-action that sequesters an activator(s) of glial-specific
gene expression. The results described below led us to quired for neurogenin to exert its full repressive effect
on the GFAP promoter, we found that Ngn1 does notfavor the third of these possibilities.
We performed a detailed deletion and substitution bind directly to the STAT binding element (data not
shown). Furthermore, the fact that multiple DNA regula-mutation analysis of the GFAP promoter to identify DNA
cis-acting elements that participate in the transcriptional tory elements contribute to Ngn1 repression of the GFAP
promoter suggests that Ngn1 might inhibit glial generepression by Ngn1. This analysis indicated that two
regions of the GFAP promoter, 21876 bp to 21546 bp activation by interfering with a transcription cofactor
that mediates the effects of multiple promoter boundand 21546 bp to 21342 bp, are involved in the repres-
sion of the GFAP promoter by Ngn1 (Figure 3B). Neither transcription factors.
Cell
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Figure 5. Ngn1 Sequesters the Transcriptional Coactivating Complex Composed of CBP/p300 and Smad1 from STAT Glial Differentiation
Factors
In CNS stem cells, coimmunoprecipitation experiments show that STAT3 associates with CBP (A). Ngn1 expression, however, causes the
disruption of the STAT3-CBP complex (A). When overexpressed in 293T cells, Ngn1 as well as AQ-Ngn1 inhibits the association between
endogenous CBP and exogenous STAT3 (B), and Ngn1 itself associates with both exogenous CBP and exogenous Smad1 (C and D). Most
importantly, in E14 rat cortex, endogenous CBP associates with endogenous Ngn1 and Smad1 (E), but not with STAT3, although STAT3 is
expressed in E14 cortex (F). In P3 SVZ, where Ngn1 is not expressed and gliogenesis is ongoing, CBP co-IPs with STAT3 (F). An antibody
against p53 was used as a negative control for the immunoprecipitation procedure (E and F). We examined whether the CBP/p300-Smad1
complex is limiting for cell differentiation, and found that overexpression of CBP and Smad1 rescues the Ngn1-mediated reduction in the
number of astrocytes (G and H). Overexpression of p300 or Smad1 also enhances the transcriptional activation by Ngn1 on the E box elements
of the NeuroD promoter (I) (*; p , 0.05).
A DNA Binding Mutant of Ngn1 that Is Incapable DNA binding mutants of Ngn1 and examined their func-
tion in neuronal induction and glial inhibition. The firstof Inducing Neuronal Differentiation Still
Inhibits Astrocyte Differentiation mutant is a deletion of the whole basic region of Ngn1
(D-Ngn1), and the second mutant contains a two aminoThe finding that Ngn1 acts in part through the STAT
binding element, yet does not bind this sequence, raised acid substitution mutation in the C terminus of the basic
region of Ngn1 (AQ-Ngn1). The AQ substitution has pre-the possibility that the DNA binding function of neuro-
genin might not be required for inhibition of gliogenesis. viously been shown to abolish the DNA binding activity
of a related bHLH protein, NeuroD2 (Farah et al., 2000).The basic regions of Ngn1, Ngn2, and NeuroD, which
are critical for DNA binding, are very similar (Sommer Using the EMSA assay, we found that both D-Ngn1 and
AQ-Ngn1 failed to bind to the E box element (Figureset al., 1996), and we found that Ngn1, in the presence
of E47, can bind to the insulin E box in an electrophoretic 4A and 4B).
When adenoviral vectors carrying either of these twomobility shift assay (EMSA), as can NeuroD (Peyton et
al., 1994) and Ngn2 (Gradwohl et al., 1996). Ngn1 mutants were introduced into neural stem cells,
the Ngn1 mutants failed to induce neurogenesis (dataTo examine whether E box binding is required for
Ngn1 to inhibit glial differentiation, we generated two not shown). However, given that there is a putative nu-
Mechanisms of Neuronal-Glial Fate Determination
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clear localization sequence (NLS) contained within neu- tween CBP-Smad1 and Ngn1 is a consequence of over-
expression, we asked whether this association occursrogenin’s basic region, it remained a possibility that
these mutants were transcriptionally inactive because in the developing cortex. We hypothesized that early in
the development of the cortex, when neurogenin expres-they could not enter the nucleus, not because the mu-
tants were unable to bind to the E box. We examined the sion is at its peak, the neurogenins bind CBP and Smad1,
thus inhibiting the ability of CBP-Smad1 to interact withsubcellular localization of the exogenous Myc-tagged
wild-type and various mutant neurogenins in mamma- STATs and to activate glial differentiation during the
time of neurogenesis. To test this idea, we examinedlian 293T cells, embryonic neural stem cells, and cortical
progenitor cells. We found that wild-type Ngn1 predomi- the association of CBP-Smad1, Ngn1, and STATs in
extracts from rat E14 cerebral cortex. In these extracts,nantly localized to the nucleus. The subcellular local-
ization of AQ-Ngn1 was indistinguishable from that of CBP was found to associate with both Ngn1 and Smad1
(Figure 5E), but not with STAT3 even though STAT3 isthe wild-type Ngn1, whereas D-Ngn1 was distributed
equally throughout the cell, as was also seen with the expressed at high levels in these extracts (Figure 5F).
In contrast, we found that STAT3 did associate withNgn1(nm) mutant control (Figure 4C).
Both of the basic domain mutants were tested for their CBP in protein extracts of postnatal day 3 (P3) cortical
subventricular zone (SVZ) where the glial-producing pre-ability to inhibit astrocyte differentiation. We found that
AQ-Ngn1, though unable to bind to the E box or induce cursor cells reside and at a time when neurogenin is no
longer expressed (Figure 5F).neurogenesis, still effectively suppresses astrocyte differ-
entiation (Figure 4D). As expected, AQ-Ngn1, unlike its Neurogenin might not only sequester CBP-Smad1
away from glial promoters, but might use these coactiva-wild-type counterpart, failed to activate the promoter of
the Ngn1 target gene, NeuroD (Figure 4E) (Huang et al., tors to promote neuronal differentiation. We considered
the possibility that the CBP and Smad1 transcriptional2000). This suggests that neurogenin can inhibit astrocyte
differentiation independent of its DNA binding function, coactivators are limiting, such that the amount of coacti-
vators present is only sufficient to promote differentia-a function that is required for neuronal induction. In
addition, the fact that D-Ngn1, which is not well localized tion of precursors into either neurons or astrocytes, but
not both. To test this idea, we overexpressed CBP orto the nucleus, is not as effective as AQ-Ngn1 in sup-
pressing glial differentiation suggests that the glial inhi- Smad1 in cortical precursors in an attempt to reverse
the suppressive effect of Ngn1 on glial differentiation.bition event occurs in the nucleus.
Overexpression of either CBP or, to a lesser extent
Smad1, resulted in a significant rescue of glial differenti-Ngn1 Sequesters a Transcriptional Coactivator
ation from Ngn1 suppression (Figures 5G and 5H). Fur-Complex Composed of CBP/p300 and Smad1
thermore, we found that both CBP/p300 and Smad1and Blocks Its Interaction with STAT Glial
potentiate the transcription of a Ngn1-responsive pro-Differentiation Factors
moter, suggesting that these two coactivators mightThe finding that Ngn1 does not require a functional E
be recruited to the Ngn1-E box transcription complexbox binding domain to suppress glial gene transcription
(Figure 5I). Taken together, these experiments suggestsuggests that Ngn1 may suppress glial differentiation
that Ngn1 sequestration of the CBP-Smad1 complexwithout inducing a downstream glial repressor. In addi-
may account in part for Ngn1’s ability to inhibit astrocytetion, the finding that multiple sites in the GFAP promoter
differentiation.together mediate the transcriptional repression by Ngn1
suggests that Ngn1 might interfere with a common tran-
scriptional coactivator. Since the mutation of the STAT Ngn1 Inhibits Glial Differentiation Partly
by Inhibiting the STAT Pathwaybinding site renders the GFAP promoter partially resis-
tant to suppression by Ngn1 (Figure 3B), we examined In addition to its ability to sequester the CBP-Smad1
complex away from STAT3, we also found that Ngn1whether Ngn1 might block the transcriptional coactiva-
tors that are known to act at the STAT binding site. inhibits the activation of the STAT signaling pathway. We
have previously shown that in older cortical progenitorsIt has previously been reported that CBP/p300 brings
Smad1 to the GFAP promoter, and binds to STATs at (E17/18) upon LIF/CNTF stimulation, the JAK-STAT sig-
naling pathway is activated and the LIF/CNTF-treatedthe STAT binding element, to induce gene transcription
(Nakashima et al., 1999). STATs and Smads do not ap- cells rapidly give rise to astrocytes. This is in contrast
to what is seen with younger cortical progenitors (E13/pear to interact directly, but do so via CBP/p300. We
hypothesized that Ngn1 might interfere with the recruit- 14), where LIF/CNTF stimulation leads to LIF receptor
activation but nonetheless leads to poor STAT activationment of CBP/p300 to the promoter of astrocyte-specific
genes by interfering with its ability to bind STAT proteins. and no direct GFAP induction (M. N. V. and M. E. G.,
unpublished observations). Given that neurogenins areIn progenitor or stem cell cultures that are actively giving
rise to astrocytes, endogenous CBP was found to inter- expressed at low levels in E17/18 cortical progenitors
and at high levels in E13/14 progenitors, we consideredact with endogenous STAT3 (Figure 5A). However, this
interaction is inhibited by ectopic expression of Ngn1 the possibility that Ngn1 expressed in E13/14 progeni-
tors might be inhibiting LIF-induced STAT phosphoryla-in these cells (Figure 5A). The ability of Ngn1 to inhibit
the association between STATs and CBP is independent tion in these cultures.
We measured the level of STAT activation using phos-of its ability to bind DNA (Figure 5B), and might result
from the fact that Ngn1 itself is capable of binding to pho-specific antibodies. In neural stem cells, LIF/CNTF
stimulation triggers the phosphorylation of STAT1 andboth CBP and Smad1 (Figures 5C and 5D).
To exclude the possibility that the association be- STAT3 at tyrosines 701 and 705, respectively. These
Cell
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Discussion
We have shown that neurogenin1, a bHLH transcription
factor, can actively inhibit gliogenesis in a manner that is
independent of its ability to induce neuronal differentiation.
Ngn1 inhibits various aspects of astrocyte differentiation,
such as the acquisition of an astrocytic morphology and
the expression of cell type–specific markers such as
GFAP and s100b, and it can do so without inducing
neurogenesis. We have uncovered a novel mechanism
of neurogenin action that does not rely on neurogenin’sFigure 6. Ngn1 Inhibits Astrocyte Differentiation by Inhibiting the
STAT Pathway ability to bind to DNA via its basic domain. Instead,
neurogenin appears to inhibit gliogenesis in at least twoBoth Ngn1 and Ngn1(nm)/control adenoviral infected CNS stem
cells were treated with LIF for 15 min. The activation of STAT1 and complementary ways: first, by binding and seques-
STAT3 was measured by Western blot analysis using phospho- tering the transcriptional cofactors CBP and Smad1 and
specific antibodies pSTAT1. Wild-type Ngn1 significantly inhibited second, by blocking the activation of STAT1 and
LIF-induced activation of both STAT1 and STAT3.
STAT3, signaling molecules that are critical inducers of
astrocyte differentiation. Neurogenin’s ability to both
promote neurogenesis and inhibit gliogenesis may allow
phosphorylation events are inhibited by the expression neurogenin to function as a potent neuronal commit-
of exogenous Ngn1 (Figures 6A and 6B). This suggests ment factor in a complex environment where extra-
that Ngn1, in addition to sequestering coactivators, di- cellular stimuli may send conflicting cell fate–inducing
rectly blocks STAT signaling. signals.
Several findings suggest that the ability of ectopically
expressed neurogenin to inhibit gliogenesis by seques-
Ngn1 Can Convert BMP from a Glial-Inducing tering the CBP-Smad complex reflects a function of
Cue to a Neuronal-inducing Factor endogenous neurogenin. First, endogenous neurogenin
The observation that endogenous Ngn1 expression sequesters the CBP-Smad complex away from STATs
changes dramatically during early cortical development in extracts from embryonic day 14 cortex, conditions
may explain not only the differing responses to LIF/ where STATs and neurogenins are expressed at physio-
CNTF at different stages of development, but also the logical levels. Second, during the development of the
differential responses to BMPs. In cortical progenitor cortex, gliogenesis does not begin until neurogenin lev-
cells, BMP has been reported to promote both neuronal els fall and STATs and CBP become capable of inter-
and glial differentiation depending on the type of culture acting with one another. Third, the absence of neuro-
used. In E13/E14 cultures, BMP stimulation results in genin and related proteins in knockout mice results in
neuronal differentiation (Li et al., 1998; Mabie et al., an inhibition of neurogenesis and increased glial differ-
1999), whereas in E17/E18 cultures and neural stem cell entiation consistent with the idea that a normal function
cultures, BMPs induce astrocyte differentiation (Gross of neurogenins is to inhibit glial differentiation (Nieto et
et al., 1996). Under culture conditions where BMPs in- al., 2001 [February issue of Neuron]) (Tomita et al., 2000).
duce astrocyte differentiation, neurogenin expression is
low (Y. S. and M. E. G., unpublished observations). Neurogenin Promotes Neuronal Differentiation
In coimmunoprecipitation experiments, we found that and Inhibits Gliogenesis via Distinct
activated Smad1 is bound to CBP regardless of whether Molecular Mechanisms
CBP is associated with Ngn1 or with STAT1/STAT3 (Fig- Cell fate specification involves the reciprocal activation
ure 5; Nakashima et al., 1999). We hypothesized that of genes related to a particular cell fate and the suppres-
when neurogenin levels are high, BMP stimulation pro- sion of genes of alternative fates. Many cell fate–
motes the association of Smad1 and CBP (either inde- specifying transcription factors can both positively regu-
pendently or in combination) with neurogenin to induce late one fate and negatively regulate alternative fates
neurogenesis. However, when endogenous neurogenin (Anderson, 1993; Lehming et al., 1994; Tajbakhsh et al.,
levels are low, as occurs in neural stem cells, exposure 1996). However, the mechanisms by which these factors
to BMPs induces the association of the Smad1-CBP inhibit alternative fates are not well understood. A recent
complex with STAT proteins leading to astrocyte differ- study demonstrates that the transcription factor Pit1
entiation. To test this hypothesis, we assessed the ef- can recruit positive or negative transcription complexes
fects of Ngn1 expression on the cells’ response to BMP to different cell type–specific promoters, depending on
treatment. Neural stem cells were infected with a Ngn1 the spacing between the two Pit1 DNA binding elements
or Ngn1(nm)/control adenovirus, and the differentia- (Scully et al., 2000). Our results suggest that the dual
tion of these cells was examined after BMP treatment. functions of Ngn1 in activating neuronal differentiation
In Ngn1-expressing cells, BMP significantly increased genes and suppressing glial-specific genes may reflect
neuronal differentiation, whereas in control cells, BMP two independent processes that are mediated by dis-
induced astrocyte differentiation (Figures 7A–7D). These tinct domains within the neurogenin protein. In particu-
findings suggest that the level of neurogenin expression lar, Ngn’s suppression of gene expression appears not
may determine whether BMP induces neuronal or glial to require binding of Ngn1 to E box elements that are
thought to be critical for Ngn1-dependent transcription.differentiation.
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Figure 7. Ngn1 Converts BMP from a Glial-
Inducing Cue to a Neuronal-Inducing Factor
Both Ngn1 and Ngn1(nm)/control (con) ade-
noviral infected CNS stem cells were treated
with BMP for two days. In Ngn1(nm)/control
cells, BMP induced astrocyte differentiation
(A and B). In Ngn1-expressing cells, BMP en-
hanced neuronal differentiation (C and D).
(E) Ngn1 inhibits glial differentiation by se-
questering CBP-Smad1 away from glial-spe-
cific genes and by inhibiting the STAT1/
STAT3 activation. CBP/p300 and Smad1,
separately or together, associate with Neuro-
genin at neural-specific promoters (such as
NeuroD), or are recruited to glial-specific
genes (such as GFAP) by activated STAT1/
STAT3, in the absence of neurogenins. Thus,
neurogenin not only directly activates neu-
ronal differentiation genes, it also inhibits glial
gene expression (*; p , 0.01).
Ngn1 Inhibits Glial Differentiation by Sequestering domains of CBP that interact with neurogenin revealed
that both an N- and a C-terminal domain are involvedthe Transcriptional Cofactor CBP/p300
Many transcription factors require CBP/p300 in order (Koyano-Nakagawa et al., 1999). Interestingly, the neu-
rogenin binding domains of CBP overlap with the STATto activate transcription, and there is evidence that the
levels of CBP/p300 are limiting, i.e., that there is compe- binding sites on CBP (but not with the Smad binding
sites). This is consistent with our finding that neurogenintition among the various families of transcription factors
for CBP/p300 binding (Goodman and Smolik, 2000). For competes with STAT proteins for binding to CBP.
By sequestering CBP, neurogenin may not only inhibitexample, nuclear steroid receptors indirectly inhibit
AP-1-dependent transcription by sequestering CBP/ STAT-mediated transcription, but may also inhibit the
function of other CBP-dependent transcription factors.p300 away from AP-1 and onto sites where the nuclear
receptors are bound (Kamei et al., 1996). Similarly, the We have found that Ngn1 also inhibits AP-1-dependent
transcription (Supplemental Data is shown on the Cellanti-adenoviral actions of interferon are attributed to
interferon’s ability to activate STATs, which then se- website at http://www.cell.com/cgi/content/full/104/3/
365/DC1). This may be relevant to Ngn’s ability to inhibitquester CBP/p300 away from the adenoviral transcrip-
tion factor E1A (Horvai et al., 1997). astrocyte differentiation since our analysis of the GFAP
promoter identified multiple sites, including an AP-1 site,Our findings suggest that during early cortical devel-
opment, endogenous Ngn1 associates with both CBP that contribute to neurogenin’s inhibition of the GFAP
promoter. Taken together, our findings and those ofand Smad1, and that the presence of neurogenin blocks
STAT binding to CBP. During the course of our study, others suggest that CBP/p300 may orchestrate broad
programs of gene expression that are relevant to cellit was reported that Xenopus neurogenin recruits CBP/
p300 to the NeuroD promoter to activate transcription fate determination. The effect of CBP/p300 on cell fate
may then be determined by the relative binding affinityand induce neurogenesis. The characterization of the
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and abundance of different transcription factors that the astrocytic features of the GFAP-positive cells so that
these cells can give rise to neurons. However, in theeither compete or cooperate with one another for bind-
ing to CBP/p300. adult brain, outside of the hippocampus and the subven-
tricular zone (which gives rise to the olfactory rostral
migratory stream), neural stem cells rarely give rise toNeurogenin Inhibits STAT Phosphorylation
neurons, possibly because these cells express very lowIn addition to sequestering the CBP-Smad1 complex, neu-
levels of neurogenic bHLH factors. We propose that therogenin also inhibits the activation of astrocyte-specific
manipulation of neurogenic bHLH factors within neuralgenes by blocking STAT activation. The mechanism by
stem cells may provide a means of enhancing the abilitywhich Ngn1 reduces the level of phospho-STAT1 and
of stem cells to generate large numbers of neurons that-STAT3 is unknown. We have preliminary data suggesting
might be useful for treating neurodegenerative disordersthat the AQ-Ngn1 can also inhibit STAT phosphorylation,
or repairing the injured nervous system.though not to the extent seen with wild-type Ngn1. This
suggests that Ngn1 inhibits STAT phosphorylation only
in part by a mechanism that is independent of Ngn1
Experimental Procedures
binding to DNA. A more detailed characterization of the
various mechanisms by which Ngn1 inhibits STAT phos- Cell Culture
phorylation is currently underway. Timed pregnant Long-Evans rats (from Charles River) were used to
prepare E13/14 or E17/18 cortical cultures as described in Bonni et
al. (1997). Cortical stem cells were derived from E13/14 cortices, asNeurogenin Expression May Determine the Timing
described in Johe et al. (1996), and cells from a second or thirdof Neuronal and Glial Generation
passage were used for differentiation studies in the absence of
The dual functions of neurogenins may help to explain bFGF. LIF/CNTF (50 ng/ml, Regeneron, and R&D Systems) or BMP7
why neurogenesis precedes and is dominant over glial (100 ng/ml) (Curis) were used for astrocyte differentiation. Mature
astrocyte cultures were generated from passaged E17/18 corticaldifferentiation during cortical development, even when
cells.gliogenic factors such as LIF or BMP are present (Shah
and Anderson, 1997; Park et al., 1999). The completion of
neurogenesis is marked by neurogenin downregulation, Retro- and Adenoviral Constructs and Infection Conditions
allowing progenitor cells to now respond to glial-induc- Ngn1 cDNA (obtained from Dr. Quifu Ma and Dr. David Anderson,
ing factors (LIF, BMPs) to produce astrocytes. In this Cal. Tech.) was cloned into a retroviral vector containing IRES-
GFP and packaged accordingly. The Ngn1-expressing adenoviralway, the temporal control of neurogenin expression may
constructs (the wild-type and mutants), all containing six myc tagsorchestrate the sequential onset of cortical neuronal
at the N terminus, were cloned into an adenoviral shuttle vectorand glial differentiation. One would predict that in the
containing a GFP expression cassette, pMZL6 (M. L. and M. E. G.,
absence of neurogenin, cortical gliogenesis might com- unpublished data). Recombinant adenoviruses were made by co-
mence at an earlier time during development. One way transfection of the shuttle plasmids with the plasmid pBHG10 into
of inhibiting neurogenic bHLH factors is by activating HEK293 cells.
the Notch signaling pathway (Ma et al., 1996, 1997; Ka-
geyama et al., 1997). When constitutively activated
Immunocytochemistry and Antibodies UsedNotch is introduced into the developing cortex, this re-
The immunostaining procedures are as described in Bonni et al.
sults in premature gliogenesis (Gaiano et al., 2000; Mor- (1997). In addition, the following antibodies were used: a rabbit anti-
rison et al., 2000). GFAP antibody (Accurate), a rabbit anti-GFP antibody (Clontech),
Another way of inhibiting neurogenin function is to and a monoclonal anti-myc tag antibody (Santa Cruz, 9E10).
generate neurogenin null mutant mice. Unfortunately,
the Ngn1/Ngn2 double knockout shows a dramatic
Transient Transfections and Luciferase Reporter Assaysupregulation of the related bHLH protein, Mash1, in cor-
Ngn1 and the various Ngn1 mutants that we generated were all
tical progenitor cells (Fode et al., 2000). Guillemot’s cloned into pcDNA3 (Invitrogen). The C-terminal flag-tagged CBP
group has recently analyzed the cortex of the Ngn2/ expression construct was provided by Dr. M. Rosenfeld (UCSD);
the p300 expression construct by Dr. Xi He (Children’s Hospital,Mash1 double knockout and found that the cortex of
Boston, MA); the Smad1 expression constructs by Dr. M. Whitman’sthe double mutants has increased numbers of glial progen-
lab (Harvard Medical School); and the NeuroD promoter series byitors, and that astrocytes are generated earlier during de-
Dr. M. J. Tsai (Baylor). For transient transfections, we used Fugen-6velopment (Nieto et al., 2001 [February issue of Neuron]). In (Boehringer Mannheim) for neural stem cells and calcium phosphate
addition, in Math3/Mash1 double knockouts, precocious for primary cortical cultures and 293T cells. The dual luciferase
glial differentiation was observed (Tomita et al., 2000). assay (Promega) was done according to the company’s recommen-
dations.These findings suggest that endogenous neurogenins
and related bHLH proteins regulate the timing of glial
production in the in vivo cortex.
Immunoprecipitation and Western Blot Analysis
For the coimmunoprecipitation assays, the cells were lysed in 0.7%
Implications of This Work for Neural Stem NP40 lysis buffer and standard Western blot analysis was per-
formed. The antibodies used for co-IP and Westerns were as follows:Cell Studies
AC238, a mouse anti-CBP (gift from Drs. R Eckner & D. Livingston,Multipotent neural stem cells have been isolated from
Harvard Medical School); a rabbit anti-Smad1 (UBI); a mouse anti-many regions of the adult brain (Gage et al., 1995). Re-
p53 (Ab-6 from Oncogene); a mouse anti-STAT1 and mouse anti-cent evidence suggests that the neural stem cells arise
STAT3 (Signal Transduction); and a mouse anti-GFAP (Sigma). The
from ependymal and/or GFAP-positive cells (Doetsch rabbit anti-Ngn1 antibody used to detect endogenous Ngn1 and
et al., 1999; Johansson et al., 1999). It is possible that the rabbit anti-phospho STAT1 and anti-phospho STAT3 were all
generated in the Greenberg Lab.neurogenic bHLH factors are involved in suppressing
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Northern Analysis Gage, F.H., Ray, J., and Fisher, L.J. (1995). Isolation, characteriza-
tion, and use of stem cells from the CNS. Annu. Rev. Neurosci. 18,Northern analysis was performed as described previously (Bonni et
al., 1997). The s100b probe was generated using the s100b cDNA 159–192.
sequence in the GenBank. Gaiano, N., Nye, J.S., and Fishell, G. (2000). Radial glial identity is
promoted by Notch1 signaling in the murine forebrain. Neuron 26,
In Vitro Transcription, Translation, and EMSA 395–404.
The TNT-T7 kit (Promega) was used to in vitro transcribe and trans- Ghosh, A., and Greenberg, M.E. (1995). Distinct roles for bFGF and
late the various Ngn1 cDNAs together with E47 cDNA (gift of Dr. A. NT-3 in the regulation of cortical neurogenesis. Neuron 15, 89–103.
Lassar, Harvard Medical School). The electric gel mobility shift assay
Goodman, R.H., and Smolik, S. (2000). CBP/p300 in cell growth,(EMSA) was performed as described in (Peyton et al., 1994) using
transformation, and development. Genes Dev. 14, 1553–1577.the RIPE3 probe.
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